BioSpace News Archive

GenFleet Therapeutics Raises $75 Million in Series C Financing Led by Huagai Capital, to Advance Innovative Pipeline Highlighting Cutting-edge Therapies

GenFleet Therapeutics today announced the completion of $75 million (~500 million RMB) series C financing.

December 31, 2021
·
3 min read
Drug Development

Nuvectis Pharma Initiates Phase 1 Clinical Trial of NXP800The Phase 1 Study Will be Comprised of Two Parts

Nuvectis Pharma, Inc. today announced the initiation of a Phase 1 clinical trial of NXP800, a novel Heat Shock Factor 1 (HSF1)-pathway inhibitor.

December 31, 2021
·
2 min read
GBB Closed the A Round Financing with Newly Joined FutureX Capital

Great Bay Bio (GBB), an AI-enabled biotechnology company, announces the participation of FutureX Capital in its Series A round fundraising.

December 31, 2021
·
2 min read
Helix BioPharma Corp. Provides Corporate Update - Dec 31, 2021

Helix BioPharma Corp., an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021.

December 31, 2021
·
7 min read
BioCapital

I-Mab Announces Upcoming Participation at January 2022 Conferences

I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced its participation in the following conferences in January 2022.

December 31, 2021
·
3 min read
Deals

BIOLIFE4D Announces Intention to Submit Draft Registration Statement for Underwritten Public Offering of Common Stock

BIOLIFE4D Corporation today announced that it intends to submit a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission in early 2022 for a proposed underwritten public offering of its common stock.

December 31, 2021
·
1 min read
Deals

Applied UV Announces Closing of $8.0 Million Underwritten Public Offering

Applied UV, Inc. today announced the closing of its previously announced underwritten public offering of 2,666,667 shares of common stock.

December 31, 2021
·
4 min read
R1 RCM to Present at the 40th Annual J.P. Morgan Healthcare Conference

R1 RCM Inc. today announced its management team will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 11:15 am ET.

December 31, 2021
·
1 min read
Business

Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles

Humacyte, Inc. today announced the appointment of Surgical Key Opinion Leaders (KOLs) Alan P. Kypson, M.D., FACS; Luigi Pascarella, M.D., FACS; and Todd E. Rasmussen, M.D., FACS, (Col, ret. USAF MC), to new advisory positions.

December 31, 2021
·
4 min read
Policy

Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application

Nutriband Inc., has announced that the Korean Intellectual Property Office has fully issued its patent titled “Abuse and Misuse Deterrent Transdermal System” which is related to the Company’s lead technology AVERSA™.

December 31, 2021
·
2 min read